Evidence map›Paper›PMID 31019242›Full record

ArticleScientific reports2019

Accurate early prediction of tumour response to PDT using optical coherence angiography.

M A Sirotkina, A A Moiseev, L A Matveev, V Y Zaitsev, V V Elagin, S S Kuznetsov, G V Gelikonov, S Y Ksenofontov, E V Zagaynova, F I Feldchtein and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. PDT-Induced Activation Enhanced by Hormone Response to Treatment.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Biomedical optics express · 2020
    Article
  12. Article
  13. Article
  14. Biomedical optics express · 2020
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

M A SirotkinaPrivolzhsky Research Medical University, Minin Square 10/1, 603950, Nizhny Novgorod, Russia. sirotkina_m@mail.ru.
A A MoiseevInstitute of Applied Physics of the Russian Academy of Sciences, Ulyanov Street 46, 603950, Nizhny Novgorod, Russia.
L A MatveevInstitute of Applied Physics of the Russian Academy of Sciences, Ulyanov Street 46, 603950, Nizhny Novgorod, Russia.
V Y ZaitsevInstitute of Applied Physics of the Russian Academy of Sciences, Ulyanov Street 46, 603950, Nizhny Novgorod, Russia.
V V ElaginPrivolzhsky Research Medical University, Minin Square 10/1, 603950, Nizhny Novgorod, Russia.ORCID http://orcid.org/0000-0003-2676-5661
S S KuznetsovPrivolzhsky Research Medical University, Minin Square 10/1, 603950, Nizhny Novgorod, Russia.
G V GelikonovInstitute of Applied Physics of the Russian Academy of Sciences, Ulyanov Street 46, 603950, Nizhny Novgorod, Russia.
S Y KsenofontovInstitute of Applied Physics of the Russian Academy of Sciences, Ulyanov Street 46, 603950, Nizhny Novgorod, Russia.
E V ZagaynovaPrivolzhsky Research Medical University, Minin Square 10/1, 603950, Nizhny Novgorod, Russia.
F I FeldchteinPrivolzhsky Research Medical University, Minin Square 10/1, 603950, Nizhny Novgorod, Russia.
N D GladkovaPrivolzhsky Research Medical University, Minin Square 10/1, 603950, Nizhny Novgorod, Russia.
A VitkinDepartments of Medical Biophysics and Radiation Oncology, University of Toronto and University Health Network, 610 University Ave., Toronto, Ontario, M5G 2M9, Canada.
Privolzhsky Research Medical University · RUInstitute of Applied Physics · RUUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prediction of tumour treatment response may play a crucial role in therapy selection and optimization of its delivery parameters. Here we use optical coherence angiography (OCA) as a minimally-invasive, label-free, real-time bioimaging method to visualize normal and pathological perfused vessels and monitor treatment response following vascular-targeted photodynamic therapy (PDT). Preclinical results are reported in a convenient experimental model (CT-26 colon tumour inoculated in murine ear), enabling controlled PDT and post-treatment OCA monitoring. To accurately predict long-term treatment outcome, a robust and simple microvascular metric is proposed. It is based on perfused vessels density (PVD) at t = 24 hours post PDT, calculated for both tumour and peri-tumour regions. Histological validation in the examined experimental cohort (n = 31 animals) enabled further insight into the excellent predictive power of the derived early-response OCA microvascular metric. The results underscore the key role of peri-tumour microvasculature in determining the long-term PDT response.

Indexed as

AngiographyAnimalsCell Line, TumorDisease Models, AnimalHumansMice, Inbred BALB CNeoplasms, ExperimentalPhotochemotherapyPrognosisReproducibility of ResultsTomography, Optical CoherenceTreatment Outcome

Identifiers

PMID31019242
PMCPMC6482310
OpenAlexW2941637589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.